Viridian Therapeutics Stock Price History
| VRDN Stock | USD 15.00 0.16 1.08% |
Below is the normalized historical share price chart for Viridian Therapeutics extending back to June 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Viridian Therapeutics stands at 15.00, as last reported on the 19th of June, with the highest price reaching 15.00 and the lowest price hitting 14.84 during the day.
If you're considering investing in Viridian Stock, it is important to understand the factors that can impact its price. As of now, Viridian Stock is not too volatile. Viridian Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0117, which indicates the firm had a 0.0117 % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Viridian Therapeutics, which you can use to evaluate the volatility of the company. Please validate Viridian Therapeutics' Variance of 14.45, coefficient of variation of (12,468), and Risk Adjusted Performance of (0.01) to confirm if the risk estimate we provide is consistent with the expected return of 0.045%. At this time, Viridian Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 19th of June 2025, Issuance Of Capital Stock is likely to grow to about 502.6 M, while Capital Stock is likely to drop about 134.3 M. . At this time, Viridian Therapeutics' Price To Sales Ratio is very stable compared to the past year. As of the 19th of June 2025, Price Book Value Ratio is likely to grow to 3.81, while Price Earnings Ratio is likely to drop (5.06). Viridian Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of June 2014 | 200 Day MA 17.8091 | 50 Day MA 13.4901 | Beta 0.461 |
Sharpe Ratio = 0.0117
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRDN |
Estimated Market Risk
| 3.85 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.05 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viridian Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viridian Therapeutics by adding Viridian Therapeutics to a well-diversified portfolio.
Price Book 2.9125 | Enterprise Value Ebitda (3.18) | Price Sales 4 K | Shares Float 67.2 M | Wall Street Target Price 38.3125 |
Viridian Therapeutics Stock Price History Chart
There are several ways to analyze Viridian Stock price data. The simplest method is using a basic Viridian candlestick price chart, which shows Viridian Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 11, 2025 | 16.09 |
| Lowest Price | April 8, 2025 | 11.02 |
Viridian Therapeutics June 19, 2025 Stock Price Synopsis
Various analyses of Viridian Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Viridian Stock. It can be used to describe the percentage change in the price of Viridian Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Viridian Stock.| Viridian Therapeutics Price Daily Balance Of Power | 1.00 | |
| Viridian Therapeutics Price Rate Of Daily Change | 1.01 | |
| Viridian Therapeutics Price Action Indicator | 0.16 |
Viridian Therapeutics June 19, 2025 Stock Price Analysis
Viridian Stock Price History Data
The price series of Viridian Therapeutics for the period between Fri, Mar 21, 2025 and Thu, Jun 19, 2025 has a statistical range of 5.07 with a coefficient of variation of 8.83. The daily prices for the period are distributed with arithmetic mean of 13.7. The median price for the last 90 days is 13.57. The company experienced 1:15 stock split on 13th of November 2020. Viridian Therapeutics paid out dividends to its shareholders on 2020-11-13.| Open | High | Low | Close | Volume | ||
06/19/2025 | 14.84 | 15.00 | 14.84 | 15.00 | ||
06/18/2025 | 14.75 | 15.35 | 14.53 | 15.00 | 530,885 | |
06/17/2025 | 15.71 | 15.84 | 14.31 | 14.84 | 806,220 | |
06/16/2025 | 16.02 | 16.05 | 15.52 | 15.94 | 828,519 | |
| 06/13/2025 | 15.22 | 15.93 | 15.18 | 15.88 | 708,745 | |
06/12/2025 | 16.11 | 16.16 | 15.40 | 15.67 | 1,069,136 | |
06/11/2025 | 15.57 | 16.29 | 15.27 | 16.09 | 1,110,230 | |
| 06/10/2025 | 14.90 | 15.52 | 14.83 | 15.42 | 665,185 | |
06/09/2025 | 14.98 | 14.98 | 14.36 | 14.86 | 548,269 | |
06/06/2025 | 14.57 | 14.86 | 14.46 | 14.68 | 396,686 | |
| 06/05/2025 | 14.04 | 14.39 | 13.85 | 14.24 | 422,106 | |
06/04/2025 | 14.63 | 14.88 | 14.11 | 14.15 | 414,551 | |
06/03/2025 | 13.89 | 14.86 | 13.54 | 14.45 | 1,058,482 | |
06/02/2025 | 14.06 | 14.59 | 13.80 | 13.97 | 783,105 | |
| 05/30/2025 | 13.90 | 14.04 | 13.39 | 13.92 | 768,725 | |
05/29/2025 | 13.53 | 14.01 | 13.37 | 13.97 | 593,505 | |
05/28/2025 | 14.00 | 14.18 | 13.38 | 13.50 | 1,075,196 | |
05/27/2025 | 13.70 | 14.03 | 13.59 | 13.93 | 984,650 | |
05/23/2025 | 13.39 | 13.66 | 13.33 | 13.57 | 645,431 | |
05/22/2025 | 13.52 | 13.87 | 13.38 | 13.67 | 568,146 | |
05/21/2025 | 13.60 | 13.85 | 13.26 | 13.66 | 1,029,201 | |
| 05/20/2025 | 12.89 | 14.23 | 12.80 | 13.82 | 1,454,406 | |
05/19/2025 | 12.83 | 13.21 | 12.51 | 12.82 | 471,519 | |
05/16/2025 | 12.63 | 13.09 | 12.48 | 12.94 | 597,678 | |
| 05/15/2025 | 12.44 | 12.67 | 12.13 | 12.62 | 504,717 | |
| 05/14/2025 | 12.85 | 13.02 | 12.07 | 12.38 | 617,925 | |
05/13/2025 | 13.16 | 13.16 | 12.60 | 12.81 | 869,767 | |
05/12/2025 | 12.81 | 13.38 | 12.75 | 13.12 | 942,955 | |
| 05/09/2025 | 12.76 | 13.13 | 12.36 | 12.39 | 655,726 | |
05/08/2025 | 12.24 | 13.63 | 11.98 | 12.78 | 1,045,453 | |
| 05/07/2025 | 12.03 | 12.38 | 11.76 | 12.29 | 1,065,483 | |
05/06/2025 | 12.94 | 13.01 | 12.00 | 12.03 | 1,181,743 | |
05/05/2025 | 13.48 | 13.62 | 13.06 | 13.12 | 558,016 | |
05/02/2025 | 13.98 | 13.99 | 13.29 | 13.62 | 1,086,013 | |
05/01/2025 | 13.45 | 13.86 | 13.14 | 13.74 | 605,709 | |
04/30/2025 | 12.99 | 13.76 | 12.92 | 13.55 | 580,850 | |
04/29/2025 | 13.37 | 13.50 | 13.09 | 13.18 | 463,189 | |
04/28/2025 | 13.40 | 13.96 | 13.27 | 13.53 | 683,510 | |
| 04/25/2025 | 13.30 | 13.56 | 13.14 | 13.50 | 524,677 | |
04/24/2025 | 13.49 | 13.68 | 13.29 | 13.56 | 394,787 | |
04/23/2025 | 14.17 | 14.61 | 13.50 | 13.51 | 625,245 | |
04/22/2025 | 13.34 | 13.87 | 13.25 | 13.76 | 984,122 | |
04/21/2025 | 12.93 | 13.72 | 12.87 | 13.13 | 927,210 | |
04/17/2025 | 12.60 | 13.15 | 12.31 | 13.13 | 803,097 | |
04/16/2025 | 12.64 | 13.02 | 12.27 | 12.65 | 1,873,232 | |
04/15/2025 | 13.21 | 14.22 | 12.18 | 12.80 | 1,696,727 | |
04/14/2025 | 12.27 | 13.46 | 12.09 | 13.30 | 1,123,405 | |
04/11/2025 | 11.40 | 12.08 | 11.11 | 12.02 | 1,208,187 | |
04/10/2025 | 11.34 | 11.65 | 10.79 | 11.41 | 1,130,026 | |
04/09/2025 | 10.73 | 11.92 | 9.90 | 11.79 | 1,553,456 | |
04/08/2025 | 12.10 | 12.34 | 10.82 | 11.02 | 1,293,479 | |
04/07/2025 | 11.55 | 12.16 | 10.88 | 11.78 | 1,153,319 | |
| 04/04/2025 | 12.28 | 12.61 | 11.31 | 11.99 | 1,938,737 | |
04/03/2025 | 12.45 | 12.68 | 11.90 | 12.65 | 1,124,319 | |
04/02/2025 | 12.41 | 13.29 | 12.32 | 13.07 | 1,028,392 | |
04/01/2025 | 13.38 | 13.47 | 12.53 | 12.56 | 1,087,663 | |
03/31/2025 | 13.98 | 13.98 | 13.24 | 13.48 | 983,684 | |
03/28/2025 | 14.67 | 14.74 | 14.19 | 14.44 | 594,046 | |
03/27/2025 | 14.22 | 14.76 | 14.12 | 14.67 | 579,309 | |
03/26/2025 | 14.72 | 14.81 | 14.03 | 14.16 | 1,049,127 | |
03/25/2025 | 15.44 | 15.44 | 14.72 | 14.80 | 755,095 |
About Viridian Therapeutics Stock history
Viridian Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Viridian is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Viridian Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Viridian Therapeutics stock prices may prove useful in developing a viable investing in Viridian Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 67.9 M | 71.3 M | |
| Net Loss | -116.9 M | -111 M |
Viridian Therapeutics Quarterly Net Working Capital |
|
Viridian Therapeutics Stock Technical Analysis
Viridian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Viridian Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Viridian Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Viridian Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Viridian to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viridian Therapeutics. If investors know Viridian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viridian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viridian Therapeutics is measured differently than its book value, which is the value of Viridian that is recorded on the company's balance sheet. Investors also form their own opinion of Viridian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viridian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viridian Therapeutics' market value can be influenced by many factors that don't directly affect Viridian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viridian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viridian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viridian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.